On 2017-03-21, Parnell Pharmaceuticals Holdings Ltd (PARNF) announced earnings per share of $-0.12 for the fiscal quarter ending 2016-12-31, missing the average analyst estimate of $-0.08.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2017-03-21 | 2016-12-31 | $-0.08 | $-0.12 |
| 2016-11-02 | 2016-09-30 | $-0.06 | $-0.27 |
| 2016-02-24 | 2015-12-31 | -- | $-0.45 |
| 2015-10-21 | 2015-09-30 | -- | $-0.13 |
| 2015-08-11 | 2015-06-30 | -- | $-0.19 |
| 2015-04-22 | 2015-03-31 | -- | $0.00 |